AI Article Synopsis
Article Abstract
Women who ingest their oral contraceptive pill (OCP) as part of a daily routine are more likely use their OCPs correctly. This trial examines the feasibility of an electronic-mail (e-mail) reminder system to improve OCP compliance. An e-mail reminder was sent to 50 new OCP users daily for 3 months. Subjects sent an e-mail reply to confirm receipt. OCP compliance was recorded on diaries. Four subjects were discontinued for not checking their e-mail. Active participants missed a median of 18% of the e-mail reminders (range: 0-65%). A follow-up visit was scheduled after completion of three OCP cycles. Of the 40 subjects returning completed diaries, 50% missed no active pills at all and 20% missed at least one in each cycle. Most found the daily e-mail somewhat (65%) or very helpful (19%) for OCP compliance. Of those continuing OCPs, 64% wanted to continue receiving e-mail reminders at the completion of the study. Because inconsistent OCP use is a significant cause of unplanned conception, the use of e-mail to improve OCP compliance has the potential to decrease unintended pregnancies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.contraception.2003.08.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating papillary thyroid cancer risk factors among women living at the central region of Iran: a case-control study.
BMC Endocr Disord
January 2025
Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Background: The etiology of thyroid cancer especially in women in not well recognized in Yazd, at the center of Iran. The aim of present study was to investigate the risk factors of thyroid cancer among women living in this province.
Methods: The present study was carried out as a case-control study, comprising women diagnosed with papillary thyroid cancer (PTC) as the case group, along with two distinct control groups sourced from different origins (i.
US regulatory compliance for medical combination products: an overview.
Front Med Technol
December 2024
Advance Academic Programs, Krieger School of Arts and Sciences, Johns Hopkins University, Washington, DC, United States.
This article provides a high-level overview of US regulatory review and approval processes for the growing field of medical combination products (CPs; those merging drugs with devices and/or biological products). US law defines drugs, medical devices, and CPs in specific ways, and the components of a CP are still subject to their respective regulations while combined. The Food and Drug Administration's Office of Combination Products (OCP) oversees the review and classification of CPs, which is based on their primary mode of action.
View Article and Find Full Text PDFDr. Nitya Anand: The Visionary Behind Saheli and the Advances in Medicinal Chemistry.
Cureus
August 2024
Research and Development, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Dr. Nitya Anand was a leading figure in Indian pharmaceutical research. His career spanned several decades, during which he significantly contributed to advancement in drug development and public health.
View Article and Find Full Text PDFOral Contraceptive Pills as a Potential Cause of Wallenberg Syndrome: A Mysterious Case.
Cureus
August 2024
Internal Medicine, LewisGale Medical Center, Roanoke, USA.
Wallenberg syndrome, also known as lateral medullary syndrome, is a rare neurological condition caused by an ischemic stroke in the posterior inferior cerebellar artery (PICA) territory of the brainstem. Here, we present a case of Wallenberg syndrome in a relatively healthy 37-year-old woman with no known risk factors besides a history of long-term oral contraceptive pill (OCP) use without prior adverse effects. The patient presented with acute onset headache that worsened in bright light, left-sided lightheadedness, dizziness, blurry vision, and non-bloody, non-bilious emesis.
View Article and Find Full Text PDFExploring the Correlation Between Papillary Thyroid Carcinoma (PTC) and the Usage of Oral Contraceptive Pills Among Affected Females.
Cureus
August 2024
Faculty of Medicine, Ibn Sina National College for Medical Studies, Jeddah, SAU.
Article Synopsis
- The study investigates the prevalence of oral contraceptive pill (OCP) usage among women diagnosed with papillary thyroid carcinoma (PTC) in a tertiary hospital in Saudi Arabia.
- Out of 58 female patients, 29.3% reported using OCPs, while 70.7% did not use them, with users having an age range of 26 to 56 years.
- The findings contribute to ongoing debates about the potential relationship between OCP use and PTC, highlighting the need for further research to clarify this link and its public health implications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!